HeartCore Enterprises, Inc. (NASDAQ:HTCR) ("HeartCore" or the "Company"), a leading enterprise software and consulting services company based in Tokyo, has formed a new division focused on developing Artificial
On September 30, the Securities and Exchange Commission (SEC) announced that it had charged eight cannabis stocks, in a stock promotion scheme that included Emerald Health Pharmaceuticals, Elegance Brands Inc.
Biolojic's BD9 is a multibody that was computationally designed as a multi specific antibody targeting IL-13 / TSLP to treat inflammatory diseases.Agreement builds on Teva's Pivot to Growth strategy to step up innovation